- Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization. Topol, E.J., Lincoff, A.M., Kereiakes, D.J., Kleiman, N.S., Cohen, E.A., Ferguson, J.J., Tcheng, J.E., Sapp, S., Califf, R.M. Am. J. Med. (2002)